<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2508245818
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Brimo-P
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BRIMONIDINE TARTRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        34.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01EA05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Brimo-P&trade; eye drops are used to lower raised<br />pressure in the eye and to treat glaucoma. Glaucoma<br />is a condition in which the pressure of fluid in the<br />eye may be high. However, some people with<br />glaucoma may have normal eye pressure.<br />Glaucoma is usually caused by a build up of the<br />fluid which flows through the eye. This build up<br />occurs because the fluid drains out of your eye more<br />slowly than it is being pumped in. Since new fluid<br />continues to enter the eye joining the fluid already<br />there, the pressure continues to rise. This raised<br />pressure may damage the back of the eye resulting<br />in gradual loss of sight.<br />Eye damage can progress so slowly that the person<br />is not aware of this gradual loss of sight.<br />Sometimes even normal eye pressure is associated<br />with damage to the back of the eye.<br />There are usually no symptoms of glaucoma. The<br />only way of knowing that you have glaucoma is to<br />have your eye pressure, optic nerve and visual field<br />checked by an eye specialist or optometrist.<br />If glaucoma is not treated it can lead to serious<br />problems, including total blindness. In fact,<br />untreated glaucoma is one of the most common<br />causes of blindness.<br />Brimo-P&trade; eye drops lower the pressure in the eye<br />by decreasing the fluid produced and helping the<br />flow of fluid out of the eye chamber.<br />Although Brimo-P&trade; eye drops help control your<br />glaucoma, it does not cure it.<br />Brimo-P&trade; eye drops are used, either alone or<br />together with other eye drops/medicines, to lower<br />raised pressure within your eye(s).<br />Brimo-P&trade; eye drops are only available with a<br />doctor&rsquo;s prescription from pharmacies.<br />Brimo-P&trade; belongs to a family of medicines called<br />alpha-adrenergic agonists.<br />Your doctor may have prescribed Brimo-P&trade; eye<br />drops for another reason. Ask your doctor if you<br />have any questions about why Brimo-P&trade; eye drops<br />have been prescribed for you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Brimo-P&trade; eye drops if:<br />&bull; If you are breast-feeding.<br />&bull; In infants/babies (from birth until 2 years).<br />&bull; you have an allergy to brimonidine tartrate or any<br />of the ingredients listed at the end of this leaflet.<br />&bull; you are taking monoamine oxidase antidepressant<br />medication.<br />&bull; the seal around the cap is broken.<br />&bull; the bottle/packaging shows signs of tampering.<br />&bull; the product does not look quite right.<br />&bull; the expiry date on the bottle or carton has passed.<br />If you are not sure whether you should start using<br />Brimo-P&trade; eye drops, talk to your doctor.<br />Safety and effectiveness in paediatric patients have<br />not been established.<br />Before you start to use it.<br />Tell your doctor if:<br />1. you have had an allergy to any other medicines or<br />any other substances, such as foods, preservatives<br />or dyes.<br />2. you have or have had any medical conditions,<br />especially the following:<br />&bull; liver or kidney disease.<br />&bull; severe, uncontrolled heart disease or poor blood<br />flow to the heart.<br />&bull; poor blood flow to the brain.<br />&bull; depression.<br />&bull; Raynaud&rsquo;s syndrome. This is a condition marked<br />by numbness, tingling and colour change (white,<br />blue, then red) in the fingers when they are exposed<br />to cold.<br />&bull; dizziness on standing up, especially when getting<br />up from a sitting or lying position.<br />&bull; If you suffer or have suffered reduced mental<br />capacity<br />&bull; If being given to a child between the age of 2 and<br />12 years because Brimo-P is not recommended for<br />use in this age group.<br />Taking other medicines<br />Tell your doctor if you are taking any other<br />medicines, including any that you buy without a<br />prescription from your pharmacy, supermarket or<br />health food shop. Some medicines and Brimo-P&trade;<br />eye drops may interfere with each other. These<br />include:<br />&bull; medicines for high blood pressure.<br />&bull; medicines used to treat some heart problems.<br />&bull; digoxin, a medicine used to treat heart failure.<br />&bull; certain medicines to treat depression, such as<br />tricyclics.<br />&bull; medicines to relieve strong pain or anaesthetics.<br />&bull; any sedative-type medicines, including alcohol<br />and antihistamines.<br />&bull; any sympathomimetic medicines. Medicines used<br />to treat asthma, severe headaches, or coughs and<br />colds may belong in the sympathomimetic group.<br />&bull; that can affect the metabolism like<br />chlorpromazine, methylphenidate and reserpine.<br />&bull; which work on the same receptor as Brimo-P, for<br />example isoprenaline and prazosin.<br />These medicines may be affected by Brimo-P&trade; eye<br />drops, or may affect how well it works. You may<br />need different amounts of your medicines, or you<br />may need to take different medicines.<br />Your doctor or pharmacist has more information on<br />medicines to be careful with or avoid while using<br />Brimo-P&trade; eye drops.<br />Pregnancy and breast-feeding<br />Tell your doctor if:<br />- you are pregnant or intend to become pregnant.<br />Your doctor will discuss the possible risks and<br />benefits of using Brimo-P&trade; during pregnancy.<br />- you are breast-feeding or intend to breast-feed.<br />Your doctor will discuss the possible risks and<br />benefits of using Brimo-P&trade; when breast-feeding.<br />Driving and using machines<br />&bull; All eye drops can cause a short term blurring of<br />vision when first used so you should wait until your<br />eyes are clear before driving or using machines.<br />If you stop using Brimo-P&trade;<br />To be effective Brimo-P&trade; must be used every day.<br />Do not stop using Brimo-P&trade; until your doctor tells<br />you to. If you have any further questions on the use<br />of this product, ask your doctor or pharmacist.&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>How much to use<br />Your doctor will tell you how many drops you need<br />to use each day. Use Brimo-P&trade; eye drops only<br />when prescribed by your doctor.<br />The usual dosage of eye drops is one drop in the<br />eye(s) every twelve hours.<br />Follow all directions given to you by your doctor<br />carefully. The directions may differ from the<br />information contained in this leaflet.<br />Use Brimo-P&trade; eye drops every day, at about the<br />same time each day, unless your doctor tells you<br />otherwise. Using your eye drops at the same time<br />each day will have the best effect on your eye<br />pressure. It will also help you remember when to<br />use the eye drops.<br />After using Brimo-P&trade;, wait at least 5-10 minutes<br />before putting any other eye drops in your eye.<br />If you are being changed from one eye drop to<br />another, follow your doctor&rsquo;s instructions carefully<br />as to when to stop the old drops and when to start<br />the new drops.<br />How to use it<br />You may find it easier to put drops in your eye<br />while you are sitting or lying down.<br />To open a new bottle of Brimo-P&trade; eye drops, first<br />tear off the protective seal from the bottle. The<br />contents are sterile if seal is intact. The seal will<br />break and you can pull it off and then throw it away.<br />- Unscrew the cap from the bottle, check the<br />dropper is clean.<br />- Pull your lower eyelid gently down, and then<br />carefully instill one drop inside the lower eyelid, in<br />the corner closest to the nose.<br />- Release the lower eyelid, and blink a few times to<br />make sure the eye is covered by the liquid.<br />- Repeat the procedure for your other eye, if it also<br />needs treatment.<br />- When you have finished, replace the protective<br />cap tightly to prevent spilling or spoilage.<br />Wait 15 minutes before replacing your contact<br />lenses.</p><p>Be careful not to touch the dropper tip against<br />your eye, eyelid or anything else to avoid<br />contaminating the eye drops. Contaminated eye<br />drops may give you an eye infection.<br />Brimo-P&trade; eye drops are for use in eyes only.<br />How long to use it<br />Brimo-P&trade; eye drops help control your condition<br />but do not cure it. Therefore Brimo-P&trade; eye drops<br />must be used every day. Continue using<br />Brimo-P&trade; eye drops for as long as your doctor<br />prescribes.<br />If you forget to use it<br />If it is almost time for your next dose, skip the<br />dose you missed and use your next dose when you<br />are meant to. Otherwise, use the drops as soon as<br />you remember, and then go back to using them as<br />you would normally.<br />If you are not sure whether to skip the dose, talk to<br />your doctor or pharmacist.<br />Do not use double the amount to make up for the<br />dose that you missed.<br />If you use too much (overdose)<br />If you accidentally put several drops in your<br />eye(s), immediately rinse your eye(s) with warm<br />water.<br />If you think that you or anyone else may have<br />swallowed any or all of the contents of a bottle of<br />Brimo-P&trade; eye drops, immediately telephone your<br />doctor for advice, or go to Accident and<br />Emergency at your nearest hospital.<br />Do this even if there are no signs of discomfort or<br />poisoning.<br />While you are using Brimo-P&trade; Eye Drops<br />Things you must do<br />Have your eye pressure checked when your eye<br />specialist says, to make sure Brimo-P&trade; eye drops<br />are working.<br />If you develop an eye infection, receive an eye<br />injury, or have eye surgery tell your doctor. Your<br />doctor may tell you to use a new container of<br />Brimo-P&trade; eye drops because of possible<br />contamination of the old one, or may advise you<br />to stop your treatment with Brimo-P&trade; eye drops.<br />If you become pregnant while using Brimo-P&trade;<br />eye drops, tell your doctor immediately.<br />If you are about to be started on any new<br />medicine, tell your doctor and pharmacist that you<br />are using Brimo-P&trade; eye drops.<br />Things you must not do<br />Do not give Brimo-P&trade; eye drops to anyone else,<br />even if they have the same condition as you.<br />Do not stop using Brimo-P&trade; eye drops without<br />first talking to your doctor. If you stop using your<br />eye drops, your eye pressures may rise again and<br />damage to your eye may occur.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Brimo-P&trade; can cause side<br />effects, although not everybody gets them. The<br />chance of having a side effect is described by the<br />following categories:<br />Very common Occurs in more than 1 out of 10<br />patients, Common Occurs in fewer than 1 out of<br />10 patients, Uncommon Occurs in fewer than 1<br />out of 100 patients, Rare Occurs in fewer than 1<br />out of 1,000 patients, Very rare occurs in fewer<br />than 1 out of 10,000 patients. The following eye<br />side effects may be seen with Brimo-P&trade;.<br />Affecting the eye<br />Very common:<br />&bull; Irritation of the eye (eye redness, burning,<br />stinging, a feeling of something in the eye,<br />itching, follicles or white spots on the see-through<br />layer which covers the surface of the eye)<br />&bull; Blurred vision &bull; An allergic reaction in the eye<br />Common:<br />&bull; Local irritation (inflammation and swelling of<br />the eyelid, swelling of the see-through layer which<br />covers the surface of the eye, sticky eyes, pain and<br />tearing) &bull; Sensitivity to light<br />&bull; Erosion on the surface of the eye and staining<br />&bull; Eye dryness &bull; Whitening of the see-through<br />layer which covers the surface of the eye<br />&bull; Abnormal vision &bull; Inflammation of the<br />see-through layer which covers the surface of the<br />eye<br />Very rare:<br />&bull; Inflammation within the eye<br />&bull; Reduction in pupil size<br />Side effects where the occurrence is unknown:<br />&bull; Itching of eyelids<br />Affecting the body<br />Very common:<br />&bull; Headache &bull; Dry mouth &bull; Tiredness/drowsiness<br />Common:<br />&bull; Dizziness &bull; Cold-like symptoms<br />&bull; Symptoms involving the stomach and digestion<br />&bull; Abnormal taste &bull; General weakness<br />Uncommon:<br />&bull; Depression &bull; Palpitations or changes in heart rate<br />&bull; Dry nose &bull; General allergic reactions<br />Rare:<br />&bull; Shortness of breath<br />Very rare:<br />&bull; Sleeplessness &bull; Fainting &bull; High blood pressure<br />&bull; Low blood pressure<br />Side effects where the occurrence is unknown:<br />&bull; Skin reactions including redness, face swelling,<br />itching, rash and widening of blood vessels.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not store above 30 OC.<br />&bull; Brimo-P&trade; eye drops are sterile when first<br />opened, it is important to keep the drops as clean<br />as possible during use.<br />&bull; Discard after 30 days of opening.<br />If your doctor tells you to stop using the eye drops<br />or they have passed their expiry date, ask your<br />pharmacist what to do with any remaining<br />solution.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Active ingredient: brimonidine tartrate.<br />Each mL contains: Brimonidine Tartrate 1.5 mg<br />Preservative:<br />Stabilized Oxychloro Complex 0.05mg.<br />Inactive ingredients: Sodium Carboxymethyl<br />cellulose, Boric Acid, Sodium Borate, Sodium<br />Chloride, Potassium Chloride, Calcium Chloride,<br />Magnesium Chloride Hexahydrate, Hydrochloric<br />acid or Sodium hydroxide (to adjust pH) and<br />water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Brimo-P™ eye drops is a Clear greenish yellow
sterile solution.
Brimo-P™ eye drops, 5 ml filled in LDPE bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co.,<br />Jeddah, Makkah Region, Saudi Arabia.<br />Tel: +966-12-6081111.<br />Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety<br />Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222,<br />Ext: 2317-2356-2340.<br />o Reporting hotline: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                06-09-2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>لعلاج الضغط المرتفع داخل العینین و &trade; &bull; تُستخدم بریمو- ب<br />كذلك الجلوكوما.<br />&bull; الجلوكوما ھي حالة یرتفع فیھا ضغط السائل الموجود داخل<br />العین و بالرغم من ذلك فإن بعض المصابین بالجلوكوما<br />یتمتعون بضغط عین طبیعي.<br />&bull; تحدث الجلوكوما عادةً عندما یتراكم السائل المتدفق داخل<br />العین. یحدث ھذا التراكم نتیجة تصریف ھذا السائل خارج<br />العین بسرعة أقل من السرعة التي یُضخ بھا داخل العین. في<br />ذلك الحین یستمر السائل الجدید في دخول العین و من ثم<br />الإنضمام إلى ذلك السائل الموجود بالفعل و حینئذ یستمر<br />الضغط في الإرتفاع. یمكن أن یتسبب إرتفاع ضغط العین في<br />إتلاف خلفیة العین ومن ثم فقدان تدریجي للبصر.<br />&bull; یمكن أن تتطور حالة تلف العین ببطء شدید لدرجة أن<br />الشخص المصاب لا یلاحظ ھذا الفقد التدریجي في البصر.<br />أحیانا یكون ضغط العین، بالرغم من كونھ طبیعي، مقترناً<br />بتلف في خلفیة العین.<br />&bull; لا توجد عادةً أعراض للجلوكوما.<br />&bull; الطریقة الوحیدة لمعرفة أنك مصاب بالجلوكوما ھي أن یقوم<br />طبیب العیون بفحص ضغط العین الخاص بك و كذلك العصب<br />البصري و المجال البصري.<br />&bull; یمكن أن تتسبب الجلوكوما في حدوث مشاكل خطیرة مثل<br />فقدان البصر الكامل إذا لم یتم علاجھا و في الواقع تُعَد<br />الجلوكوما من أكثر الأسباب شیوعاً لفقدان البصر.<br />بخفض ضغط العین المرتفع عن طریق &trade; &bull; تقوم بریمو- ب<br />إنقاص انتاج السائل الموجود داخل العین و المساعدة على<br />تدفقھ خارج تجویف العین.<br />تساعدك على السیطرة على &trade; &bull; بالرغم من أن بریمو- ب<br />حالة الجلوكوما إلا أنھا لا تعالجھا.<br />إما بمفردھا أو مع قطرات أخرى &trade; &bull; تُستخدم قطرة بریمو- ب<br />أو أدویة لخفض ضغط عینیك المرتفع.<br />للعین عن طریق وصفة طبیة فقط &trade; &bull; تتوفر قطرة بریمو- ب<br />تُصرف من الصیدلیات.<br />لعائلة من الأدویة تُسمَّى ناھضات &trade; &bull; تنتمي بریمو- ب<br />المستقبلات الأَدْرینِیَّةٌ الأَلْفاوِیَّة.<br />لسبب آخر. &trade; &bull; قد یصف لك طبیبك بریمو- ب<br />&bull; إسأل طبیبك إذا كان لدیك أي إستفسارات عن سبب وصف<br />لك. &trade; بریمو- ب</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ذا: &trade; لا تستخدم قطرة بریمو- ب<br />&bull; إذا كنت ترضعین طفلك رضاعة طبیعیة.<br />&bull; عند الرضع / الأطفال (من الولادة وحتى ۲ سنة).<br />&bull; كنت تعاني من حساسیة تجاه بریمونیدین تارتارات. أو تجاه<br />أي من المكونات المدرجة في آخر ھذه النشرة.<br />(MAO) &bull; كنت تتناول مثبطات انزیم أُكسیدازُ أُحادِيِّ الأَمین<br />أو مضادات للإكتئاب.<br />&bull; كان اللحام الضامن حول الغطاء مكسور.<br />&bull; ظھرت على الزجاجة أو العبوة علامات العبث.<br />&bull; كان لا یبدو المستحضر بصورة جیدة.<br />&bull; كان التاریخ المدون على العبوة قد تخطى تاریخ الصلاحیة.<br />إذا كنت غیر متأكداً ما إذا كان علیك البدء في استخدام قطرة<br />تحدث إلى طبیبك. ،&trade; بریمو- ب<br />مع الأطفال بعد. &trade; لم یثبت مدى أمان و فعالیة قطرة بریمو- ب<br />قبل البدء في الاستخدام، أخبر طبیبك إذا:<br />۱- كنت قد عانیت من حساسیة تجاه أي من الأدویة أو المواد<br />الأخرى كالطعام و المواد الحافظة و الأصباغ.<br />۲- كنت تعاني أو عانیت سابقاَ من أي حالات مرضیة خاصةً:<br />&bull; أمراض الكبد أو الكلى.<br />&bull; أمراض القلب الحادة الغیر خاضعة أو الغیر مستجیبة<br />للعلاج.<br />&bull; تدفق دم غیر كافٍ للقلب أو المخ. &bull; إكتئاب.<br />&bull; متلازمة رینود و ھي حالة تتسم بتنمیل و وخز و تغیر في<br />لون الأصابع (أبیض ثم أزرق ثم أحمر) عند تعرضھا للطقس<br />البارد.<br />&bull; الشعور بالدوار عند الوقوف خاصةً عندما یكون الشخص<br />في وضع الجلوس أو الرقود.<br />&bull; إذا كنت تعاني أو عانیت انخفاض القدرة العقلیة<br />&bull; إذا كانت تعطى لطفل یتراوح عمره بین ۲ و ۱۲ سنة لأن<br />في ھذه الفئة العمریة. &trade; غیر موصى بإستخدام بریمو- ب<br />إستخدام أدویة أخرى<br />قم بإخبار طبیبك إذا كنت تتناول أي أدویة أخرى بما في ذلك<br />الأدویة التي قمت بشرائھا بدون وصفة طبیة من الصیدلیة أو<br />السوبر ماركت أو متجر الأغذیة الصحیة. قد تتفاعل بعض<br />و تشمل تلك الأدویة: &trade; الأدویة مع قطرة بریمو- ب<br />&bull; أدویة ضغط الدم المرتفع.<br />&bull; الأدویة المستخدمة لعلاج بعض مشاكل القلب.<br />&bull; الدیجوكسین و ھو دواء یستخدم لعلاج ھبوط القلب.<br />&bull; بعض الأدویة المستخدمة لعلاج الإكتئاب مثل مُضادَّاتُ<br />الاكْتِئابِ الثُّلاثِیَّةُ الحَلَقات.<br />&bull; الأدویة المستخدمة لتسكین الألم أو المبنجات &quot;مواد<br />التخدیر&quot;.<br />&bull; أي أدویة من النوع المھدئ مثل الكحولیات و مضادات<br />الھیستامین.<br />&bull; أي أدویة داعمة للجھاز العصبي الودي و ینتمي لھذه<br />المجموعة الأدویة المستخدمة لعلاج نوبات الربو و الصداع<br />الحاد أو الكحة والبرد.<br />&bull; الأدویة التي یمكن أن تؤثر على عملیة التمثیل الغذائي مثل<br />الكلوربرومازین، المیثیلفینیدیت وریزیربین.<br />،&trade; &bull; الأدویة التي تعمل على نفس المستقبلات مثل بریمو- ب<br />على سبیل المثال إیزوبرینالین و برازوسین.<br />أو &trade; یُمكن أن تتأثر ھذه الأدویة باستخدام قطرة بریمو- ب<br />.&trade; تؤثر ھي على فعالیة قطرة بریمو- ب<br />یُمكن أن تحتاج إلى كمیات أو أنواع مختلفة من الأدویة التي<br />تستخدمھا. إن طبیبك أو الصیدلي لدیھم معلومات أكثر عن<br />مدى أمان الأدویة التي تستخدمھا أثناء استخدامك قطرة<br />أو تلك التي یجب تجنبھا. &trade; بریمو- ب<br />الحمل و الرضاعة<br />أخبري طبیبك إذا:<br />&bull; كنتِ حاملاً أو تخططین أن تصبحي حاملاً. سوف یخبرك<br />طبیبك عن المخاطر و المنافع الممكنة عند استعمال<br />أثناء الحمل. &trade; بریمو- ب<br />&bull; كنتِ أماً مرضعة أو تنوین أن تكوني مرضعة. سوف<br />یخبرك طبیبك عن المخاطر و المنافع الممكنة عند استعمال<br />أثناء قیامك بالرضاعة الطبیعیة. &trade; بریمو- ب<br />قیادة السیارة و إستخدام الآلات<br />&bull; قد تحدث غشاوة في الإبصار لفترة قصیرة بعد إستخدام<br />قطرة للعین مباشرة . یجب أن تمتنع عن قیادة &trade; بریمو- ب<br />السیارة أو إستخدام الآلات حتى تستعید الرؤیة الواضحة.<br />&trade; إذا توقفت عن استخدام بریمو- ب<br />یومیا لضمان فعالیتھ. &trade; یجب استخدام بریمو- ب<br />حتى یخبرك طبیبك. إذا &trade; لا تتوقف عن استخدام بریمو- ب<br />كان لدیك أي أسئلة أخرى عن استخدام ھذا المنتج، إسأل<br />طبیبك أو الصیدلي &quot;.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>۳. كیفیة استخدام بریمو- ب<br />الكمیة المستخدمة:<br />&bull; سوف یُخبرك طبیبك عن عدد النقاط التي تحتاجھا كل الیوم.<br />فقط عندما یوصفھا لك طبیبك. &trade; استخدم قطرة بریمو- ب<br />&bull; الجرعة المعتادة لقطرات العین ھي نقطة واحدة في إحدى<br />العینین أو كلتاھما كل ۱۲ ساعة.<br />&bull; إتبع بحرص كل التعلیمات الموجھة لك من قبل طبیبك. قد<br />تختلف التعلیمات عن تلك المذكورة في ھذه النشرة.<br />كل یوم في نفس التوقیت إلّا إذا &trade; &bull; استخدم قطرة بریمو- ب<br />أخبرك الطبیب بخلاف ذلك.<br />&bull; استخدامك لقطرة العین كل یوم في نفس التوقیت سوف<br />یعطیك أفضل النتائج بالنسبة لضغط عینك المرتفع. و سوف<br />یساعدك أیضاً على تذكر موعد استخدامك لقطرة العین.<br />قبل أن وضع &trade; ۱۰ دقائق بعد استخدام بریمو- ب - &bull; إنتظر ٥<br />أي قطرات أخرى للعین.<br />&bull; إذا كنت تحولت من أحدى أنواع القطرات إلى أخرى فاتبع<br />تعلیمات طبیبك بعنایة بخصوص متى تتوقف عن النوع القدیم<br />و تبدأ في الجدید.<br />كیفیة الاستخدام:<br />&bull; یمكن أن تجد أنھ من الأسھل لك وضع قطرة العین و انت<br />في وضع الجلوس أو مستلقٍ.<br />جدیدة، اقطع الحلقة الواقیة من &trade; &bull; لفتح زجاجة بریمو- ب<br />حول غطاء الزجاجة و تضمن ھذه الحلقة أن المحتوى معقم<br />طالما أنھا سلیمة. سوف تنكسر ھذه الحلقة وسیكون بامكانك<br />جذبھا و التخلص منھا.<br />&bull; قم بلف الغطاء من الزجاجة، وتحقق من أن القطارة نظیفة.<br />&bull; إسحب الجفن السفلي إلى أسفل برفق، ومن ثم ضع بعنایة<br />قطرة واحدة داخل الجفن السفلي، في الزاویة الأقرب إلى<br />الأنف.<br />&bull; حرر الجفن السفلي، أغلق وافتح العین عدة مرات للتأكد من<br />تغطیة العین عن طریق السائل.<br />في كلتا العینین كرر نفس &trade; &bull; إذا كنت تستخدم بریمو- ب<br />الخطوات للعین الأخرى. إذا كانت ھي أیضاً تحتاج للعلاج.<br />&bull; قم بإعادة غطاء الزجاجة الى مكانھ مباشرة بعد الإستخدام<br />وقم بإحكام الغلق.<br />انتظر ۱٥ دقیقة قبل استخدامك لعدساتك اللاصقة مرة أخرى.<br />كن حریصاً على عدم لمس طرف القطّارة لعینك أو الجفن أو<br />أي شيء آخر لتجنب تلوث القطرة. سمكن أن تتسبب قطرة<br />العین الملوثة في إصابتة عینك بالعدوى.<br />كقطرة للعین فقط. &trade; تُستخدم بریمو- ب</p><p>كم مدة استخدام قطرة بریمو- ب<br />في التحكم في حالتك و لكن لا &trade; تُساعد قطرة بریمو- ب<br />كل یوم. &trade; تعالجھا. ولذلك فإنھ یجب استخدام قطرة بریمو- ب<br />للمدة التي وصفھا لك &trade; استمر في استخدام قطرة بریمو- ب<br />طبیبك.<br />&trade; إذا نسیت استخدام قطرة بریمو- ب<br />&bull; انھ میعاد جرعتك التالیة، قُم بتخطي الجرعة التي نسیتھا و<br />خذ جرعتك التالیة في میعادھا أو قم باستخدام القطرة فور<br />تذكرك ثم عُد إلى نظامك المعتاد.<br />&bull; إذا كنت غیر متأكداً من تركك للجرعة التي نسیتھا أو لا<br />اسأل طبیبك أو الصیدلي.<br />&bull; لا تستخدم كمیة مضاعفة لتعویض الجرعة التي نسیتھا.<br />إذا استخدمت جرعة مفرطة<br />&bull; إذا قمت بوضع عدة نقاط في عینیك عن طریق الخطأ،<br />اغسل عینیك فوراً بالماء الدافئ.<br />&bull; إذا كنت تعتقد انك أو أي شخص آخر قد ابتلع بعض أو كل<br />اتصل بطبیبك أو بمركز &trade; محتویات زجاجة بریمو- ب<br />السموم أو للإستشارة أو اذھب لقسم الحوادث و الطوارئ في<br />أقرب مستشفى. قم بھذا الإجراء حتى لو لم تلاحظ أي علامات<br />للتعب أو التسمم.<br />&trade; أثناء استخدامك قطرة بریمو- ب<br />أشیاء یجب علیك فعلھا<br />قُم بفحص ضغط عینیك عندما یطلب طبیب العیون ذلك للتأكد<br />.&trade; من فعالیة قطرة بریمو- ب<br />أخبر طبیبك إذا أُصبت بعدوى أو جرح في العین أو قمت<br />بعمل جراحة. یُمكن أن یطلب من طبیبك استعمال زجاجة<br />جدیدة بسبب إمكانیة تلوث الزجاجة القدیمة أو &trade; بریمو- ب<br />.&trade; یطلب منك التوقف عن العلاج بقطرة بریمو- ب<br />أخبري &trade; إذا أصبحتي حاملاً أثناء استخدامك لقطرة بریمو- ب<br />طبیبك على الفور.<br />إذا كنت على وشك البدء في تناول أي دواء جدید أخبر طبیبك<br />.&trade; أو الصیدلي انك تستخدم قطرة بریمو- ب<br />أشیاء لا یجب علیك فعلھا<br />لأي شخص آخر حتى وإن &trade; &bull; لا تصف قطرة بریمو- ب<br />كانت حالتھ مماثلة لحالتك.<br />بدون التحدث أولاً &trade; &bull; لا تتوقف عن استخدام قطرة بریمو- ب<br />مع طبیبك. إذا توقفت عن استخدام قطرة العین الخاصة بك من<br />تلقاء نفسك فقد یُعاود ضغط عینك في الارتفاع و من ثم<br />تُصاب بالتلف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة, یمكن الإصابة ببعض الآثار الجانبیة بسبب<br />على الرغم من عدم حدوثھا للجمیع. , &trade; استخدام بریمو- ب<br />توصف فرصة حدوث الآثار الجانبیة حسب الفئات التالیة:<br />شائعة جداً تحدث في أكثر من ۱ من كل ۱۰ مرضى،<br />شائعة تحدث في أقل من ۱ من كل ۱۰ مرضى،<br />غیر شائعة تحدث في أقل من ۱ من كل ۱۰۰ مریض،<br />نادرة تحدث في أقل من ۱ من كل ۱۰۰۰ مریض،<br />نادرة جداً تحدث في أقل من ۱ من كل ۱۰,۰۰۰ مریض.<br />.&trade; قد تشاھد الآثار الجانبیة التالیة مع بریمو- ب<br />التي تؤثر على العین<br />شائعة جداً:<br />&bull; تھیج العین (احمرار بالعین، حرقان ، لسع، الشعور بشيء<br />في العین، حكة، حویصلات أو بقع بیضاء على الطبقة التي<br />ینظر من خلالھا والتي تغطي سطح العین)<br />&bull; عدم وضوح الرؤیة &bull; رد الفعل التحسسي في العین<br />شائعة:<br />&bull; تھیج موضعي (التھاب وتورم الجفن، تورم الطبقة التي<br />ینظر من خلالھا والتي تغطي سطح العین، عیون لزجة، ألم و<br />تمزق) &bull; حساسیة للضوء<br />&bull; تآكل على سطح العین وتلوین &bull; جفاف العین<br />&bull; إبیضاض الطبقة التي ینظر من خلالھا والتي تغطي سطح<br />العین<br />&bull; رؤیة غیر طبیعیة &bull; التھاب الطبقة التي ینظر من خلالھا<br />والتي تغطي سطح العین<br />نادرة جداً:<br />&bull; التھاب داخل العین<br />&bull; تقلیص حجم بؤبؤ العین<br />الآثار الجانبیة غیر المعروف تكرارھا:<br />&bull; حكة في الجفون<br />التي تؤثر على الجسم<br />شائعة جداً:<br />&bull; صداع &bull; جفاف الفم &bull; تعب / نعاس<br />شائعة:<br />&bull; دوخة &bull; أعراض مثل أعراض البرد<br />&bull; الأعراض التي تشمل المعدة والھضم<br />&bull; طعم غیر طبیعي &bull; ضعف عام<br />غیر شائعة:<br />&bull; اكتئاب &bull; خفقان أو تغییرات في معدل نبضات القلب<br />&bull; أنف جاف &bull; تفاعلات حساسیة عامة<br />نادرة:<br />&bull; ضیق في التنفس<br />نادر جدا:<br />&bull; الأرق &bull; الإغماء &bull; ارتفاع ضغط الدم<br />&bull; انخفاض ضغط الدم<br />الآثار الجانبیة غیر المعروف تكرارھا:<br />&bull; ردود فعل الجلد بما في ذلك الاحمرار، تورم الوجھ، حكة و<br />طفح جلدي واتساع الأوعیة الدمویة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; یحفظ نع اًدیعب متناول و مرأى الأطفال .<br />&bull; یحفظ في درجة حرارة لا تزید عن ۳۰ درجة مئویة.<br />تكون معقمة عند فتحھا لأول مرة &trade; &bull; قطرات العین بریمو- ب<br />من المھم أن تظل القطرات نظیفة بأكبر قدر ممكن خلال<br />الاستخدام.<br />&bull; یتلف الدواء بعد ۳۰ یوماً من فتح الغطاء.<br />إذا طلب منك طبیبك أن تتوقف عن استخدام قطرة العین أو إذا<br />كان تاریخ الصلاحیة قد انتھى، إستشر الصیدلي عن كیفیة<br />التصرف مع أي محلول متبقي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما ھي مكونات بریمو- ب<br />المادة الفعالة: بریمونیدین تارتارات.<br />كل ۱ مل یحتوي على ۱٫٥ ملغ بریمونیدین تارتارات.<br />المادة الحافظة: أوكسیكلورو مركب ثابت ۰,۰٥ ملغ.<br />المكونات الغیر فعالة: صودیوم كربوكسي میثیل سلیلوز ،<br />حمض البوریك ، بورات الصودیوم ، كلورید الصودیوم ،<br />كلورید البوتاسیوم ، كلورید الكالسیوم ، كلورید الماغنسیوم<br />ھیكساھیدرات ، حمض الھیدروكلوریك أو ھیدروكسید<br />الصودیوم (لضبط درجة الحموضة) وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>طرة للعین محلول نقي لونھ أصفر مخضر. &trade; بریمو- ب<br />قطرة للعین ، ٥ مل في قطارة من البولي إیثیلین &trade; بریمو- ب<br />منخفض الكثافة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسویق و المصنع:<br />شركة مصنع جمجوم للأدویة،<br />جدة، منطقة مكة، المملكة العربیة السعودیة.<br />+۹٦٦-۱۲- ھاتف: ٦۰۸۱۱۱۱<br />+۹٦٦-۱۲- فاكس: ٦۰۸۱۲۲۲<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبیھ:<br />&bull; المملكة العربیة السعودیة:<br />- المركز الوطني للتیقظ و السلامة الدوائیة<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفیذیة للتیقظ وإدارة الأزمات. o<br />+۹٦٦-۱۱- ھاتف: ۲۰۳۸۲۲۲ o<br />۲۳٤۰-۲۳٥٦- تحویلة: ۲۳۱۷<br />الخط الساخن للإبلاغ: ۱۹۹۹۹ o<br />npc.drug@sfda.gov.sa : برید إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الإلكتروني o<br />&bull; دول الخلیج الأخرى:<br />- الرجاء الاتصال بالمؤسسات و الھیئات الوطنیة في كل<br />دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            06-09-2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Brimo-P 0.15%.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is brimonidine tartrate 0.15% (1.5 mg/mL).
The Other ingredients are Stabilized Oxychloro Complex (SOC), Sodium Carboxymethyl Cellulose
Sodium Borate, Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride
Hexahydrate, Hydrochloric acid and or Sodium Hydroxide, Water for Injection
For full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ophthalmic solution.
Clear greenish yellow sterile solution, free from visible particles,
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Brimo-P 0.15% is a relatively selective alpha-2 adrenergic receptor agonist indicated for the reduction<br />of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The recommended dose is one drop of Brimo-P 0.15% in the affected eye(s) three times daily,<br />approximately 8 hours apart. Brimo-P 0.15% ophthalmic solution may be used concomitantly with<br />other topical ophthalmic drug products to lower intraocular pressure. If more than one topical<br />ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.<br />Additional information on special populations:<br />Renal/hepatic impairment:<br />Brimonidine Tartrate 0.15% has not been studied in patients with hepatic impairment.<br />Brimonidine Tartrate 0.15% has not been studied in patients with renal impairment. The effect of<br />dialysis on brimonidine pharmacokinetics in patients with renal failure is not known.<br />Pediatric population:<br />Brimonidine Tartrate 0.15% is contraindicated in children under the age of 2 years (see 4.3<br />CONTRAINDICATIONS).</p><p>During post marketing surveillance, apnea, bradycardia, coma, hypotension, hypothermia, hypotonia,<br />lethargy, pallor, respiratory depression, and somnolence have been reported in infants receiving<br />brimonidine. The safety and effectiveness of brimonidine tartrate have not been studied in children<br />below the age of 2 years.<br />In a well-controlled clinical study conducted in pediatric glaucoma patients (ages 2 to 7 years) the most<br />commonly observed adverse reactions with brimonidine tartrate ophthalmic solution 0.2% dosed three<br />times daily were somnolence (50-83% in patients ages 2 to 6 years) and decreased alertness. In<br />pediatric patients 7 years of age (&gt;20 kg), somnolence appears to occur less frequently (25%).<br />Approximately 16% of patients on brimonidine tartrate ophthalmic solution discontinued from the<br />study due to somnolence.<br />Geriatric patients:<br />No overall differences in safety or effectiveness have been observed between elderly and other adult<br />patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4.3.1 Neonates and Infants (under the age of 2 years) Brimonidine Tartrate 0.15% is contraindicated in
neonates and infants (under the age of 2 years). 4.3.2 Hypersensitivity Reactions Brimonidine Tartrate
0.15% is contraindicated in patients who have exhibited a hypersensitivity reaction to any component
of this medication in the past.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4.4.1 Potentiation of Vascular Insufficiency</p><p>Brimonidine Tartrate 0.15% may potentiate syndromes associated with vascular insufficiency.<br />Brimonidine Tartrate 0.15% should be used with caution in patients with depression, cerebral or<br />coronary insufficiency, Raynaud&rsquo;s phenomenon, orthostatic hypotension, or thromboangiitis obliterans.</p><p>4.4.2 Severe Cardiovascular Disease<br />Although brimonidine tartrate ophthalmic solution had minimal effect on the blood pressure of patients<br />in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease.<br />4.4.3 Contamination of Topical Ophthalmic Products After Use<br />There have been reports of bacterial keratitis associated with the use of multiple-dose containers of<br />topical ophthalmic products. These containers had been inadvertently contaminated by patients who, in<br />most cases, had a concurrent corneal disease or a disruption of the ocular epithelial surface.</p><p>Patients should be instructed that ocular solutions, if handled improperly or if the tip of the dispensing<br />container contacts the eye or surrounding structures, can become contaminated by common bacteria<br />known to cause ocular infections. Serious damage to the eye and subsequent<br />loss of vision may result from using contaminated solutions. Always replace the cap after using. If<br />solution changes color or becomes cloudy, do not use. Do not use the product after the expiration date<br />marked on the bottle.<br />Patients also should be advised that if they have ocular surgery or develop an intercurrent ocular<br />condition (e.g., trauma or infection), they should immediately seek their physician&rsquo;s advice concerning<br />the continued use of the present multidose container.<br />If more than one topical ophthalmic drug is being used, the drugs should be administered at least five<br />minutes apart.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4.5.1 Antihypertensives/Cardiac Glycosides<br />Because Brimonidine Tartrate 0.15% may reduce pulse and blood pressure, caution in using drugs such<br />as antihypertensives and/or cardiac glycosides with Brimonidine Tartrate 0.15% is advised.<br />4.5.2 CNS Depressants<br />Although specific drug interaction studies have not been conducted with Brimonidine Tartrate 0.15% ,<br />the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates,<br />sedatives, or anesthetics) should be considered.<br />4.5.3 Tricyclic Antidepressants<br />Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine. It is<br />not known whether the concurrent use of these agents with Brimonidine Tartrate 0.15% in humans can<br />lead to resulting interference with the IOP lowering effect. Caution is advised in patients taking<br />tricyclicantidepressants which can affect the metabolism and uptake of circulating amines.<br />4.5.4 Monoamine Oxidase Inhibitors<br />Monoamine oxidase (MAO) inhibitors may theoretically interfere with the metabolism of brimonidine<br />and potentially result in an increased systemic side-effect such as hypotension. Caution is advised in<br />patients taking MAO inhibitors which can affect the metabolism and uptake of circulating amines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category B: Teratogenicity studies have been performed in animals.</p><p>Brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats<br />and days 6 through 18 in rabbits. The highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and<br />rabbits (5.0 mg/kg/day) achieved AUC exposure values 360- and 20-fold higher, or 260- and 15-fold<br />higher, respectively, than similar values estimated in humans treated with Brimonidine Tartrate 0.15%<br />1 drop in both eyes three times daily.<br />There are no adequate and well-controlled studies in pregnant women; however, in animal studies,<br />brimonidine crossed the placenta and entered into the fetal circulation to a limited extent. Because<br />animal reproduction studies are not always predictive of human response, Brimonidine Tartrate 0.15%<br />should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to<br />the fetus.<br />Nursing Mothers: It is not known whether brimonidine tartrate is excreted in human milk, although in<br />animal studies, brimonidine tartrate has been shown to be excreted in breast milk. Because of the<br />potential for serious adverse reactions from Brimonidine Tartrate 0.15% in nursing infants, a decision<br />should be made whether to discontinue nursing or to discontinue the drug, taking into account the<br />importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other similar medications, Brimonidine Tartrate 0.15% may cause fatigue and/or drowsiness in<br />some patients. Patients who engage in hazardous activities should be cautioned of the potential for<br />a decrease in mental alertness. It may also cause blurred vision or visual disturbance in some<br />patients. The patient should wait until these symptoms have cleared before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000<br />to &lt;1/1,000); very rare (&lt;1/10,000), unknown (cannot be estimated from available data).<br />Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed<br />in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another<br />drug and may not reflect the rates observed in practice.<br />Very common adverse reactions occurring in approximately 10-20% of the subjects receiving<br />brimonidine ophthalmic solution (0.1-0.2%) included: allergic conjunctivitis, conjunctival hyperemia,<br />and eye pruritus. Adverse reactions occurring in approximately 5-9% included: burning sensation,<br />conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.<br />Common adverse reactions occurring in approximately 1-4% of the subjects receiving brimonidine<br />ophthalmic solution (0.1-0.2%) included: abnormal taste, allergic reaction, asthenia, blepharitis,<br />blepharoconjunctivitis, blurred vision, bronchitis, cataract, conjunctival edema, conjunctival&nbsp;hemorrhage, conjunctivitis, cough, dizziness, dyspepsia, dyspnea, epiphora, eye discharge, eye dryness,<br />eye irritation, eye pain, eyelid edema, eyelid erythema,<br />fatigue, flu syndrome, follicular conjunctivitis, foreign body sensation, gastrointestinal disorder,<br />headache, hypercholesterolemia, hypotension, infection (primarily colds and respiratory infections),<br />insomnia, keratitis, lid disorder, pharyngitis, photophobia, rash, rhinitis, sinus infection, sinusitis,<br />somnolence, stinging, superficial punctate keratopathy, tearing, visual field defect, vitreous detachment,<br />vitreous disorder, vitreous floaters, and worsened visual acuity.<br />Uncommon adverse reactions were reported in less than 1% of subjects: corneal erosion, hordeolum,<br />nasal dryness, and taste perversion.<br />The following reactions have been identified during post marketing use of brimonidine tartrate<br />ophthalmic solutions in clinical practice. Because they are reported voluntarily from a population of<br />unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for<br />inclusion due to either their seriousness, frequency of reporting, possible causal connection to<br />brimonidine tartrate ophthalmic solutions, or a combination of these factors, include: bradycardia,<br />depression, hypersensitivity, iritis, keratoconjunctivitis sicca, miosis, nausea, skin reactions (including<br />erythema, eyelid pruritus, rash, and vasodilation), syncope, andtachycardia. Apnea, bradycardia, coma,<br />hypotension, hypothermia, hypotonia, lethargy, pallor, respiratory depression, and somnolence have<br />been reported in infants receiving brimonidine tartrate ophthalmic solutions.</p><p>To reports any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2340<br />o Reporting hotline: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Very limited information exists on accidental ingestion of brimonidine in adults; the only adverse<br />reaction reported to date has been hypotension. Symptoms of brimonidine overdose have been reported<br />in neonates, infants, and children receiving Brimonidine Tartrate 0.15% as part of medical treatment of<br />congenital glaucoma or by accidental oral ingestion. Treatment of an oral overdose includes supportive<br />and symptomatic therapy; a patent airway should be maintained.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Description:<br />Pharmacotherapeutic group: Sympathomimetics used in ophthalmic &ndash; glaucoma treatment<br />ATC Code is S01EA05<br />Mechanism of Action: Brimonidine Tartrate ophthalmic solution 0.15%, sterile, is a relatively selective<br />alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent) with a peak ocular<br />hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and<br />humans suggest that brimonidine tartrate has a dual mechanism of action by reducing aqueous humor<br />production and increasing uveoscleral outflow.<br />CLINICAL STUDIES:<br />Elevated IOP presents a major risk factor in glaucomatous field loss. The higher the level of IOP, the<br />greater the likelihood of optic nerve damage and visual field loss. Brimonidine tartrate has the action of<br />lowering intraocular pressure with minimal effect on cardiovascular and pulmonary parameters.Clinical<br />studies were conducted to evaluate the safety, efficacy, and acceptability of brimonidine tartrate<br />ophthalmic solution 0.15% compared with Brimonidine Tartrate 0.2% administered three times- daily<br />in patients with open-angle glaucoma or ocular hypertension. Those results indicated that brimonidine<br />tartrate ophthalmic solution 0.15% is comparable in IOP lowering effect to brimonidine tartrate<br />ophthalmic solution 0.2%, and effectively lowers IOP in patients with open-angle glaucoma or ocular<br />hypertension by approximately 2-6 mmHg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Description:<br />Pharmacotherapeutic group: Sympathomimetics used in ophthalmic &ndash; glaucoma treatment<br />ATC Code is S01EA05<br />Mechanism of Action: brimonidine tartrate ophthalmic solution 0.15%, sterile, is a relatively selective<br />alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent) with a peak ocular<br />hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and<br />humans suggest that brimonidine tartrate has a dual mechanism of action by reducing aqueous humor<br />production and increasing uveoscleral outflow.<br />CLINICAL STUDIES:<br />Elevated IOP presents a major risk factor in glaucomatous field loss. The higher the level of IOP, the<br />greater the likelihood of optic nerve damage and visual field loss. Brimonidine tartrate has the action of<br />lowering intraocular pressure with minimal effect on cardiovascular and pulmonary parameters.Clinical<br />studies were conducted to evaluate the safety, efficacy, and acceptability of brimonidine tartrate&nbsp;ophthalmic solution 0.15% compared with Brimonidine Tartrate 0.2% administered three times- daily<br />in patients with open-angle glaucoma or ocular hypertension. Those results indicated that brimonidine<br />tartrate ophthalmic solution 0.15% is comparable in IOP lowering effect to brimonidine tartrate<br />ophthalmic solution 0.2%, and effectively lowers IOP in patients with open-angle glaucoma or ocular<br />hypertension by approximately 2-6 mmHg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenesis, Mutagenesis, Impairment of Fertility (Nonclinical Toxicology)<br />No compound-related carcinogenic effects were observed in either mice or rats following a 21-month<br />and 24-month study, respectively. In these studies, dietary administration of brimonidine tartrate at<br />doses up to 2.5 mg/kg/day in mice and 1 mg/kg/day in rats achieved 150 and 120 times or 90 and 80<br />times, respectively, the plasma Cmax drug concentration in humans treated with one drop of<br />Brimonidine Tartrate 0.2% or 0.15% into both eyes 3 times per day, the recommended daily human<br />dose.<br />Brimonidine tartrate was not mutagenic or clastogenic in a series of in vitro and in vivo studies<br />including the Ames bacterial reversion test, chromosomal aberration assay in Chinese Hamster Ovary<br />(CHO) cells, and three in vivo studies in CD-1 mice: a host-mediated assay, cytogenetic study, and<br />dominant lethal assay.<br />Reproduction and fertility studies in rats with brimonidine tartrate demonstrated no adverse effect on<br />male or female fertility at doses which achieve up to approximately 125 and 90 times the systemic<br />exposure following the maximum recommended human ophthalmic dose of Brimonidine Tartrate 0.1%<br />or 0.15%, respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Stabilized Oxychloro Complex (SOC), Sodium Carboxymethyl Cellulose<br />Sodium Borate, Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride<br />Hexahydrate, Hydrochloric acid and or Sodium Hydroxide, Water for Injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
Discard after 30 days of opening
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>LDPE opaque bottle with LDPE nozzle and HDPE cap.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company
P.O. Box 6267
Jeddah 21442, Saudi Arabia.
Tel: 00966-12-6081111
Fax: 00966-12-6081222
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                03-Oct-2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>